Search - tctmd.com

Displaying 621 - 640 of 1117

Sort: Relevancy | Date

News

Mortality and CVD Decline in Patients With Diabetes, but Biggest Strides Seen for Nonfatal Outcomes

Michael O'Riordan

April 13, 2017

News Daily News

Yo-Yo a No-No: Fluctuating Body Weight May Increase Morbidity and Mortality Among CAD Patients

L.A. McKeown

April 06, 2017

News Daily News

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

Todd Neale

April 05, 2017

News Daily News

MR CLEAN: Sustained Benefit of Endovascular Therapy for Acute Ischemic Stroke

Michael O'Riordan

April 05, 2017

News Daily News

Opened Data: Analysis of Requests for NHLBI Trial Data May Allay Some Concerns

Shelley Wood

March 29, 2017

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

News Conference News ACC 2017

RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest

Yael L. Maxwell

March 20, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

Todd Neale

March 18, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Conference News ACC 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

L.A. McKeown

March 18, 2017

News Conference News ACC 2017

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

Yael L. Maxwell

March 17, 2017

News Conference News ACC 2017

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

Yael L. Maxwell

March 17, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Features

Be It Resolved: As Evidence Mounts in Favor of a Brain-Heart Connection, Stress Should Be on the Radar During CVD Diagnosis

Yael L. Maxwell

January 16, 2017

News Daily News

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

Shelley Wood

December 02, 2016

News Daily News

England Lags Behind US in Repair of Abdominal Aortic Aneurysms

L.A. McKeown

November 28, 2016

News Daily News

Anemia Common in ACS Patients, Linked with Higher Mortality

Michael O'Riordan

November 23, 2016

Advertisement

Mortality and CVD Decline in Patients With Diabetes, but Biggest Strides Seen for Nonfatal Outcomes

Yo-Yo a No-No: Fluctuating Body Weight May Increase Morbidity and Mortality Among CAD Patients

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

MR CLEAN: Sustained Benefit of Endovascular Therapy for Acute Ischemic Stroke

Opened Data: Analysis of Requests for NHLBI Trial Data May Allay Some Concerns

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Be It Resolved: As Evidence Mounts in Favor of a Brain-Heart Connection, Stress Should Be on the Radar During CVD Diagnosis

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

England Lags Behind US in Repair of Abdominal Aortic Aneurysms

Anemia Common in ACS Patients, Linked with Higher Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content